Paper41398607
Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.
Wang J and 15 others. J Nanobiotechnology, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles. Papers, record 41398607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398607
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Nanoparticles | Major topic |
| Muscle, Smooth, Vascular | Major topic |
| Macrophages | Major topic |
| Selenium | Major topic |
| Oligodeoxyribonucleotides | Major topic |
| Myocytes, Smooth Muscle | Major topic |
| Immunosuppressive Agents | Major topic |
| Animals | |
| Mice | |
| Phenotype | |
| Male | |
| Mice, Inbred C57BL | |
| Oxidative Stress | |
| Mice, Knockout, ApoE |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024BSGZ21 | Science Foundations of Guangdong Second Provincial General Hospital | PubMed | ||
| TJGC-2025002 | Science Foundations of Guangdong Second Provincial General Hospital | PubMed | ||
| 82300506 | National Natural Science Foundation of China | PubMed | ||
| 82300958 | National Natural Science Foundation of China | PubMed | ||
| 82270471 | National Natural Science Foundation of China | PubMed | ||
| 2023M731315 | China Postdoctoral Science Foundations | PubMed | ||
| 2023M731316 | China Postdoctoral Science Foundations | PubMed | ||
| 2022A1515010253 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 202206010033 | Major Project of Science and Technology of Guangzhou | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36935493 | Theranostic applications of selenium nanomedicines against lung cancer. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36935493 | PubMed |
| 2 | 25686105 | A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. | Nat Med | 2015 | https://conductscience.org/library/papers/25686105 | PubMed |
| 3 | 28643462 | Selenium-Doped Carbon Quantum Dots for Free-Radical Scavenging. | Angew Chem Int Ed Engl | 2017 | https://conductscience.org/library/papers/28643462 | PubMed |
| 4 | 39061065 | Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39061065 | PubMed |
| 5 | 34273166 | Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells. | Cardiovasc Res | 2022 | https://conductscience.org/library/papers/34273166 | PubMed |
| 6 | 35008765 | NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008765 | PubMed |
| 7 | 31200144 | Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy. | Biomaterials | 2019 | https://conductscience.org/library/papers/31200144 | PubMed |
| 8 | 29875409 | Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. | Nature | 2018 | https://conductscience.org/library/papers/29875409 | PubMed |
| 9 | 34505766 | Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles. | ACS Nano | 2021 | https://conductscience.org/library/papers/34505766 | PubMed |
| 10 | 35041278 | Engineering CXCL12 Biomimetic Decoy-Integrated Versatile Immunosuppressive Nanoparticle for Ischemic Stroke Therapy with Management of Overactivated Brain Immune Microenvironment. | Small Methods | 2022 | https://conductscience.org/library/papers/35041278 | PubMed |
| 11 | 34639053 | The Impact of Selenium Deficiency on Cardiovascular Function. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639053 | PubMed |
| 12 | 22381456 | Selenium and human health. | Lancet | 2012 | https://conductscience.org/library/papers/22381456 | PubMed |
| 13 | 38145971 | Hypertensive Pressure Mechanosensing Alone Triggers Lipid Droplet Accumulation and Transdifferentiation of Vascular Smooth Muscle Cells to Foam Cells. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38145971 | PubMed |
| 14 | 40690813 | Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies. | Redox Biol | 2025 | https://conductscience.org/library/papers/40690813 | PubMed |
| 15 | 28062653 | Anticoagulation, atherosclerosis, and heart failure. | Eur Heart J Cardiovasc Pharmacother | 2017 | https://conductscience.org/library/papers/28062653 | PubMed |
| 16 | 29315675 | Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. | Med Res Rev | 2018 | https://conductscience.org/library/papers/29315675 | PubMed |
| 17 | 39400451 | Intracellular Redox Environment Determines Cancer-normal Cell Selectivity of Selenium Nanoclusters. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/39400451 | PubMed |
| 18 | 39568027 | Neutrophil extracellular traps facilitate liver inflammation/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39568027 | PubMed |
| 19 | 28981106 | NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28981106 | PubMed |
| 20 | 34121366 | Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics. | Adv Healthc Mater | 2021 | https://conductscience.org/library/papers/34121366 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42985392 | Selenium Nanoparticles in Atherosclerosis and Non-Alcoholic Fatty Liver Disease: A Comprehensive Review of Therapeutic Mechanisms, Targeted Delivery, and Translational Prospects. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42985392 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398607
GET https://conductscience.org/api/papers/v1/41398607/references?page=2